DelMar Pharmaceuticals Inc (OTCQX US:DMPI)

0.84
Delayed Data
As of Apr 24
 +0.075 / +9.80%
Today’s Change
0.62
Today|||52-Week Range
1.23
+3.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income0.000.000.000.00--
General Expenses1.2M1.6M1.1M1.3M
 
 
 
 
 
Research And Development566.1K618.9K671.6K612.2K
 
 
 
 
 
Total Operating Expenses1.2M1.6M1.1M1.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.2M-1.6M-1.1M-1.3M
 
 
 
 
 
Extraordinary Credit372.5K0.00--291.7K
 
 
 
Extraordinary Charge---1.6M-201.4K--
 
 
 
Interest Expense On Debt2.0K2.0K2.1K0.00
 
 
 
 
Other Expenses-34.8K-11.9K-2.4K-100.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-866.0K-3.2M-1.3M-1.1M
 
 
 
 
 
Net Income-866.0K-3.2M-1.3M-1.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.5M31.7M36.5M37.8M
 
 
 
 
 
Shares To Calculate EPS Diluted31.5M31.7M36.5M37.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03-$0.10-$0.04-$0.03
 
 
 
 
 
EPS Diluted-$0.03-$0.10-$0.04-$0.03
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account